- Home
- DRRX vs DRIO Comparison
DRRX vs DRIO Comparison
Compare DRRX & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRRX
- DRIO
- Stock Information
- Founded
- DRRX 1998
- DRIO 2011
- Country
- DRRX United States
- DRIO United States
- Employees
- DRRX N/A
- DRIO N/A
- Industry
- DRRX Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- DRRX Health Care
- DRIO Health Care
- Exchange
- DRRX Nasdaq
- DRIO Nasdaq
- Market Cap
- DRRX 26.3M
- DRIO 27.9M
- IPO Year
- DRRX 2000
- DRIO N/A
- Fundamental
- Price
- DRRX $0.80
- DRIO $0.69
- Analyst Decision
- DRRX Buy
- DRIO Strong Buy
- Analyst Count
- DRRX 2
- DRIO 1
- Target Price
- DRRX $5.00
- DRIO $4.00
- AVG Volume (30 Days)
- DRRX 54.3K
- DRIO 610.8K
- Earning Date
- DRRX 03-26-2025
- DRIO 03-27-2025
- Dividend Yield
- DRRX N/A
- DRIO N/A
- EPS Growth
- DRRX N/A
- DRIO N/A
- EPS
- DRRX N/A
- DRIO N/A
- Revenue
- DRRX $8,594,000.00
- DRIO $23,052,000.00
- Revenue This Year
- DRRX $54.32
- DRIO $34.42
- Revenue Next Year
- DRRX N/A
- DRIO $32.86
- P/E Ratio
- DRRX N/A
- DRIO N/A
- Revenue Growth
- DRRX N/A
- DRIO N/A
- 52 Week Low
- DRRX $0.70
- DRIO $0.56
- 52 Week High
- DRRX $1.88
- DRIO $2.26
- Technical
- Relative Strength Index (RSI)
- DRRX 49.63
- DRIO 49.72
- Support Level
- DRRX $0.73
- DRIO $0.67
- Resistance Level
- DRRX $0.83
- DRIO $0.74
- Average True Range (ATR)
- DRRX 0.05
- DRIO 0.06
- MACD
- DRRX 0.01
- DRIO 0.01
- Stochastic Oscillator
- DRRX 63.57
- DRIO 63.16
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.